HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID


Forgot password

Remember my login

New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals

Today's Issue of Medical Device Daily

Sunday, January 22, 2017

Today's Headlines

Amedica seeks $4.5M while awaiting FDA clearance for cancellous-structure implant

Amedica Corp. is looking to raise $4.5 million through a public offering slated to close on Tuesday. The funding raise comes in the middle of the Salt Lake City-based company's bid to obtain clearance for its Valeo cancellous-structure ceramic cervical (C+Csc) implant. Amedica has been waiting for the FDA to green light the device for nearly two years now. (See Medical Device Daily, Feb. 13, 2015.)

IBM Watson Health scores another deal with FDA, but keeps mum on revenue

SAN FRANCISCO IBM Watson Health was a star at this year's J.P. Morgan Healthcare conference, announcing a trio of deals with high profile players. The latest was with the U.S. FDA to work together to define a way for to exchange health data across a variety of technology platforms with an initial focus on oncology data.

Post-merger Abbott moves into 2017 with renewed focus, still faces hurdles

SAN FRANCISCO – Abbott Laboratories came off a blockbuster year in 2016 filled with acquisitions, divestitures and lawsuits. Executives of the company took to the podium during the 35th annual J.P. Morgan Healthcare conference to give a look back to last year and to provide a prelude of what lies ahead in 2017.

MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com